We employed Eμ-MYC/Cas9 doubly transgenic mice and a fetal liver derived HSPC transplantation approach to investigate the tumour suppressive role of TFAP4 during c-MYC-driven lymphoma development. The gene discussed is TFAP4; the disease is neoplasm.